top of page
Understanding Cardiac Mass Removal: Techniques Using Continuous Aspiration with Dr. Abdallah El Sabbagh, Dr. Hady Lichaa on the BackTable Cardiology Podcast
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Cardiology

Episode # 34  •  05 May 2026

Understanding Cardiac Mass Removal: Techniques Using Continuous Aspiration

From clot to clear flow, minimally invasive aspiration devices are PAVE-ing the way for safer treatment of endocarditis and cardiac masses. In this BackTable Cardiology episode, host Dr. Hady Lichaa sits down with Dr. Abdallah El Sabbagh to discuss percutaneous continuous-flow aspiration for right- and select left-sided endocarditis and cardiac masses.

This podcast is supported by

Angiodynamics

Timestamps

00:00 - Introduction
03:43 - Lessons in Fibroelastoma
12:01 - Imaging Workup
14:24 - Transesophageal Echocardiography (TEE) vs Intracardiac Echocardiography (ICE)
17:52 - AngioVac System Components
20:33 - Access Strategy, Sheath Size and Flow Rates
23:41 - Adjunct Tools and Retrieval Options
31:35 - Using Continuous Aspiration
47:16 - Percutaneous AngioVac Vegetation Extraction (PAVE) Trial
53:17 - Future Devices Wishlist

Resources

You may also like

See more of the content that's relevant to your practice.

More about this episode

Dr. El Sabbagh provides guidance on removing papillary fibroelastomas, emphasizing matching technique to mass characteristics and combining tools such as continuous aspiration with electrosurgical snaring to address adherent stalks. Their conversation covers patient selection for off-label endocarditis intervention, including intravenous drug use and Cardiac Implantable Electronic Device (CIED) lead infections, use of aspiration as definitive therapy, and imaging/workflow preferences. Dr. El Sabbagh details the AngioVac system, access strategies, adjunct devices, mitigating complications, and registry outcomes. He touches on the need for prospective studies, including the Percutaneous AngioVac Vegetation Extraction (PAVE) clinical trial. To finish the conversation, Drs. Lichaa and El Sabbagh look ahead to building future devices and provide advice on creating multidisciplinary programs as well as training pathways.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page